Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « A. Lees »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
A. Lang < A. Lees < A. M. Bonnet  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000545 (1999) Yves Agid [France] ; E. Ahlskog [France] ; A. Albanese [France] ; D. Calne [France] ; T. Chase [France] ; J. De Yebenes [France] ; S. Factor [France] ; S. Fahn [France] ; O. Gershanik [France] ; C. Goetz [France] ; W. Koller [France] ; M. Kurth [France] ; A. Lang [France] ; A. Lees [France] ; P. Lewitt [France] ; D. Marsden [France] ; E. Melamed [France] ; P. P. Michel [France] ; Y. Mizuno [France] ; J. Obeso [France] ; W. Oertel [France] ; W. Olanow [France] ; Werner Poewe [France] ; Pierre Pollak [France] ; S. Przedzorski [France] ; N. Quinn [France] ; R. Raisman-Vozari [France] ; A. Rajput [France] ; F. Stocchi [France] ; E. Tolosa [France]Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpoint
000578 (1998) Olivier Rascol [France] ; K. Sieradzan [Royaume-Uni] ; H. Peyro-Saint-Paul [France] ; C. Thalamas [France] ; C. Brefel-Courbon [France] ; J. M. Senard [France] ; P. Ladure [France] ; J. L. Montastruc [France] ; A. Lees [Royaume-Uni]Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy
000654 (1992) Emre [Suisse] ; U. K. Rinne [Finlande] ; A. Rascol [France] ; A. Lees [Royaume-Uni] ; Yves Agid [France] ; X. Lataste [Suisse]Effects of a selective partil D1 agonist, CY 208‐243, in de novo patients with Parkinson disease
000660 (1992) M. Emre [Suisse] ; U. K. Rinne ; A. Rascol ; A. Lees ; Yves Agid [France] ; X. LatasteEffects of a selective partial D1 agonist, CY 208-243, in De Novo patients with Parkinson disease

List of associated KwdEn.i

Nombre de
documents		Descripteur
2Adult
2Chemotherapy
2Dose-Response Relationship, Drug
2Drug Administration Schedule
2Humans
2Parkinson Disease (drug therapy)
2Parkinson disease
2Treatment
1Aged
1Agonist
1Animals
1Antiparkinson Agents (administration & dosage)
1Antiparkinson Agents (adverse effects)
1Antiparkinson Agents (therapeutic use)
1Antiparkinson agent
1Brain (drug effects)
1Bromocriptine (therapeutic use)
1Cell Death (drug effects)
1Crossover study
1D1 Dopamine receptor
1D1‐receptor agonists
1Dopamine agonist
1Dopamine agonists
1Double blind study
1Drug Therapy, Combination
1Efaroxan
1Female
1Human
1Indoles (therapeutic use)
1Levodopa (administration & dosage)
1Levodopa (adverse effects)
1Male
1Middle Aged
1Motricity
1Neurologic Examination (drug effects)
1Parkinson Disease (physiopathology)
1Phenanthridines (therapeutic use)
1Randomization
1Receptors, Dopamine (drug effects)
1Receptors, Dopamine (physiology)
1Receptors, Dopamine D1
1Supranuclear ophthalmoplegia
1α2-Adrenergic receptor

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "A. Lees" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "A. Lees" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    A. Lees
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024